| 41 |
Sustained AhR Activation leading to Rodent Liver Tumours |
Undefined |
BY-SA |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
|
856: Formation, Hepatocellular and Bile duct tumors
|
Under Review |
1.7 |
| 46 |
AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC) |
Ted Simon |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
378: Tumorigenesis, Hepatocellular carcinoma
|
Under Review |
1.8 |
| 167 |
Early-life estrogen receptor agonism leading to endometrial adenosquamous carcinoma via promotion of sine oculis homeobox 1 progenitor cells |
Travis Karschnik |
BY-SA |
111: Agonism, Estrogen receptor
|
1070: Increased, adenosquamous carcinomas of endometrium
|
|
|
| 168 |
GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. |
Charles Wood |
BY-SA |
None
|
1079: Increased, Adenomas/carcinomas (mammary)
|
|
|
| 200 |
Estrogen receptor activation leading to breast cancer |
Molly M Morgan |
Open for adoption |
111: Agonism, Estrogen receptor
|
1193: N/A, Breast Cancer
|
|
|
| 212 |
Histone deacetylase inhibition leading to testicular atrophy |
Shihori Tanabe |
BY-SA |
1502: Histone deacetylase inhibition
|
1506: Testicular atrophy
|
WPHA/WNT Endorsed |
1.52 |
| 220 |
Cyp2E1 Activation Leading to Liver Cancer |
Francina Webster |
BY-SA |
1391: Activation of Cyp2E1
|
1395: Liver Cancer
|
WPHA/WNT Endorsed |
1.24 |
| 272 |
Deposition of energy leading to lung cancer |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
1556: Increase, lung cancer
|
WPHA/WNT Endorsed |
1.56 |
| 293 |
Increased DNA damage leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1194: Increase, DNA damage
|
3 AOs
|
Under Development |
1.80 |
| 294 |
Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer |
Jessica Helm |
BY-SA |
1632: Increase in reactive oxygen and nitrogen species (RONS)
|
4 AOs
|
Under Development |
1.80 |
| 295 |
Early-life stromal estrogen receptor activation by endocrine disrupting chemicals in the mammary gland leading to enhanced cancer risk |
Andrea Hindman |
BY-SA |
None
|
None
|
Under Development |
1.79 |
| 298 |
Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer |
Shihori Tanabe |
BY-SA |
1115: Increase, Reactive oxygen species
|
1651: Treatment-resistant gastric cancer
|
Under Review |
1.58 |
| 303 |
Frustrated phagocytosis-induced lung cancer |
Carole Seidel |
BY-SA |
1668: Frustrated phagocytosis
|
1670: Lung cancer
|
Under Development |
1.86 |
| 315 |
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response |
Yasuhiro Yoshida |
BY-SA |
1715: Inhibition of JAK3
|
1719: Impairment of T-cell dependent antibody response
|
Under Development |
1.74 |
| 316 |
Trypsin inhibition leading to pancreatic acinar cell tumors |
Shigeru Hisada |
BY-SA |
1720: Trypsin inhibition
|
1725: Pancreatic acinar cell tumors
|
Under Development |
1.60 |
| 409 |
Frustrated phagocytosis leads to malignant mesothelioma |
Penny Nymark |
BY-SA |
1668: Frustrated phagocytosis
|
1090: Increased, mesotheliomas
|
|
|
| 439 |
Activation of the AhR leading to metastatic breast cancer |
Louise Benoit |
BY-SA |
18: Activation, AhR
|
1982: metastatic breast cancer
|
Under Review |
1.105 |
| 440 |
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia |
Kalyan Gayen |
All rights reserved |
1046: Suppression, Estrogen receptor (ER) activity
|
2 AOs
|
Under Development |
1.104 |
| 443 |
DNA damage and mutations leading to Metastatic Breast Cancer |
Usha Adiga |
BY-SA |
1669: Increased, DNA damage and mutation
|
1982: metastatic breast cancer
|
Under Development |
1.103 |
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 459 |
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 472 |
DNA adduct formation leading to kidney failure |
Manoe Janssen |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
759: Increased, Kidney Failure
|
|
|
| 474 |
Succinate dehydrogenase inactivation leads to cancer by promoting EMT |
Sylvie Bortoli |
BY-SA |
2118: Succinate dehydrogenase, inhibited
|
885: Increase, Cancer
|
Under Development |
1.106 |
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 493 |
ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity |
Min Ji Kim |
All rights reserved |
2126: Estrogen receptor alpha inactivation
|
2129: Metabolically unhealthy Obesity
|
|
|